Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
Armanini, D., Karbowiak, I., & Funder, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 163
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 801–900 of 1,001
Pathophysiology of adrenal hypertension
Moneva, M. H., & Gómez-Sánchez, C. E. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.28670 · Cited by 32
Baker, M. E., & Fanestil, D. D. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90178-u · Cited by 32
Effects of spironolactone on systolic blood pressure in experimental diabetic rats
Liu, Y.-J., Nakagawa, Y., Toya, K., Wang, Y., Saegusa, H., Nakanishi, T., & Ohzeki, T. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00055.x · Cited by 32
Steroid receptors: distribution along the nephron.
Farman, N. (1992) · PubMed · Cited by 32
Walker, B. R. (1994) · Steroids · doi:10.1016/0039-128x(94)90081-7 · Cited by 32
Raza, K., Hardy, R., & Cooper, M. S. (2010) · Rheumatology · doi:10.1093/rheumatology/keq212 · Cited by 31
Dimerization of the Glucocorticoid Receptor and Its Importance in (Patho)physiology: A Primer
Timmermans, S., Vandewalle, J., & Libert, C. (2022) · Cells · doi:10.3390/cells11040683 · Cited by 31
The regulation of cell growth and survival by aldosterone
Dooley, R., Harvey, B. J., & Thomas, W. (2010) · Frontiers in bioscience · doi:10.2741/3697 · Cited by 31
“In the classical aldosterone target tissues such as kidney and colon, the specificity of aldosterone for MR is maintained by the enzyme hydroxysteroid dehydrogenase type 2 (11-beta-HSD2) which reduces the abundant cortisol/corticosterone to inactive 11-keto metabolites, thus allowing preferential access for aldosteron…”
BackgroundIn silico structure-function analysis of pathological variation in the HSD11B2 gene sequence
Manning, J. R., Bailey, M. A., Soares, D. C., Dunbar, D. R., & Mullins, J. J. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2010 · Cited by 32
“gov/pmc/articles/PMC2929884/?report=printable[16/08/2013 22:26:27] enzyme 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) (24).”
McEwen, B. S., & Chattarji, S. (2006) · Springer eBooks · doi:10.1007/978-0-387-30405-2_14 · Cited by 31
Calcium Checks cyclic AMP - Corticosteroid Feedback in Adenohypophysial Corticotrophs
Antoni, F. A. (1996) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1996.tb00703.x · Cited by 31
Rauz, S., Walker, E. A., Murray, P. I., & Stewart, P. M. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00088-5 · Cited by 31
Reduced 11 -Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy
Escher, G., Vogt, B., Beck, T. D., Guntern, D., Frey, B. M., & Frey, F. J. (1998) · Endocrinology · doi:10.1210/endo.139.4.5891 · Cited by 31
Goto, J., Otsuka, F., Yamashita, M., Suzuki, J., Otani, H., Takahashi, H., Miyoshi, T., Mimura, Y., Ogura, T., & Makino, H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90840.2008 · Cited by 31
Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings
Ullian, M. E., Hazen‐Martin, D. J., Walsh, L. G., Davda, R. K., & Egan, B. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1346 · Cited by 31
Obeyesekere, V. R., Li, K. X. Z., Ferrari, P., & Krozowski, Z. S. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00106-8 · Cited by 32
Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine
Nakagawa, K., & Ishizaki, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00066-2 · Cited by 31
Steroids and electrical activity in the brain
Joëls, M., Hesen, W., Karst, H., & de Kloet, E. R. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90285-2 · Cited by 31
11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney
Escher, G., Frey, F. J., & Frey, B. M. (1994) · Endocrinology · doi:10.1210/endo.135.1.8013341 · Cited by 31
Steroid hormones and hypertension: The cortisol-cortisone shuttle
Stewart, P. M., Whorwood, C. B., & Walker, B. R. (1993) · Steroids · doi:10.1016/0039-128x(93)90104-u · Cited by 30
Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies
Gómez-Sánchez, C. E., Warden, M. P., Gomez-Sanchez, M. T., Hou, X., & Gómez-Sánchez, E. P. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.004 · Cited by 30
“which inactivates cortisol or corticosterone [10,11].”
Molecular biology of 11β-hydroxylase and 11β-hydroxysteroid dehydrogenase enzymes
White, P. C., Pascoe, L., Curnow, K. M., Tannin, G. M., & Rösler, A. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90309-7 · Cited by 30
Pilipuk, G. P., & Galigniana, M. D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00166-4 · Cited by 30
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Usa, K., Singh, R., Netzel, B. C., Liu, Y., Raff, H., & Liang, M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2006 · Cited by 30
“11 -HSD2 in the distal nephron inactivates glucocorticoids and allows aldosterone to be functionally significant (12, 35).”
BackgroundIngram, M. C., Wallace, A. M., Collier, A., Fraser, R., & McConnell, J. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02744.x · Cited by 30
Analysis of the human gene encoding the kidney isozyme of 11β-hydroxysteroid dehydrogenase
Agarwal, A. K., Rogerson, F. M., Mune, T., & White, P. C. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00196-4 · Cited by 30
Diederich, S., Quinkler, M. O., Burkhardt, P., Großmann, C., Bähr, V., & Oelkers, W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3021.x · Cited by 30
CYP11B2 polymorphisms and cardiovascular risk factors
Davies, E., & Kenyon, C. J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200307000-00008 · Cited by 30
Corticosteroid Receptors, 11β-Hydroxysteroid Dehydrogenase, and the Heart
Sheppard, K. E. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01003-3 · Cited by 30
Morris, D. J., & Souness, G. W. (1996) · Endocrine Research · doi:10.1080/07435809609043778 · Cited by 30
Corticosteroid receptors and 11β-hydroxysteroid dehydrogenase isoforms in rat intestinal epithelia
Sheppard, K. E., Li, K. X. Z., & Autelitano, D. J. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g541 · Cited by 30
Cellular mechanisms of action of mineralocorticoid hormones
Johnson, J. P. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90042-x · Cited by 30
Expression of 11β-OHSD along the nephron of mammals and humans
Kenouch, S., Alfaidy, N., Bonvalet, J. P., & Farman, N. (1994) · Steroids · doi:10.1016/0039-128x(94)90084-1 · Cited by 30
Nashev, L. G., Vuorinen, A., Praxmarer, L., Chantong, B., Cereghetti, D., Winiger, R. R., Schuster, D., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046958 · Cited by 29
Vítků, J., Stárka, L., Bičíková, M., Hill, M., Heráček, J., Kolátorová, L., & Hampl, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.007 · Cited by 29
“This colocalization in vivo therefore allows aldosterone to bind to MR [13].”
Leskinen, M. H., Hautaniemi, E. J., Tahvanainen, A., Koskela, J., Päällysaho, M., Tikkakoski, A., Kähönen, M. A. P., Kööbi, T., Niemelä, O. J., Mustonen, J. T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105607 · Cited by 29
Gene expression profiling of the canine placenta during normal and antigestagen-induced luteolysis
Nowak, M., Rehrauer, H., Ay, S. S., Fındık, M., Boos, A., Kautz, E., & Kowalewski, M. P. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.05.019 · Cited by 29
“HSD11B2 is responsible for conversion of cortisol to its inactive form, cortisone (Ulick et al., 1977; Funder et al., 1988).”
BackgroundTwo Mineralocorticoid Receptor–Mediated Mechanisms of Pendrin Activation in Distal Nephrons
Ayuzawa, N., Nishimoto, M., Ueda, K., Hirohama, D., Kawarazaki, W., Shimosawa, T., Marumo, T., & Fujita, T. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019080804 · Cited by 29
Stein, M. K., & Loewy, A. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.085 · Cited by 26
“The latter group of neurons contains the enzyme 11 β-hydroxysteroid dehydrogenase type 2 (HSD2) as well as mineralocorticoid receptors, making them highly selective to aldosterone (Funder et al., 1988).”
BackgroundGaligniana, M. D., Pilipuk, G. P., Kanelakis, K. C., Burton, G., & Lantos, C. P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.041 · Cited by 29
“An answer to this conundrum appeared to lie in the inactivating action of the enzyme 11 -hydroxysteroid dehydrogenase-2 (11 HSD-2) (Funder et al., 1988; Edwards et al., 1988).”
BackgroundArginine Vasotocin and Isotocin: Towards their Role in Fish Osmoregulation
Kulczykowska, E. (2007) · Science Publishers eBooks · doi:10.1201/b10994-7 · Cited by 29
Corticosterone 6 beta-hydroxylase in A6 epithelia: a steroid-inducible cytochrome P-450
Grogan, W. M., Phillips, V., Schuetz, E. G., Guzelian, P. S., & Watlington, C. O. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c480 · Cited by 29
Shelat, S. G., Fluharty, S. J., & Flanagan‐Cato, L. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00794-x · Cited by 29
Furosemide Inhibits 11β-Hydroxysteroid Dehydrogenase Type 21
Fuster, D. G., Escher, G., Vogt, B., Ackermann, D., Dick, B., Frey, B. M., & Frey, F. J. (1998) · Endocrinology · doi:10.1210/endo.139.9.6175 · Cited by 29
Murotsuki, J., Gagnon, R. J., Pu, X.-D., & Yang, K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.1.234 · Cited by 29
Molecular and cellular determinants of mineralocorticoid selectivity
Farman, N. (1999) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199901000-00008 · Cited by 29
11β-Hydroxysteroid Dehydrogenase and Its Inhibitors in Hypertensive Pregnancy
Walker, B. R., Williamson, P. M., Brown, M. A., Honour, J. W., Edwards, C. R. W., & Whitworth, J. A. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.626 · Cited by 29
Feinstein, M. B., & Schleimer, R. P. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.3.3560 · Cited by 29
Characteristics and regulation of 11β-hydroxysteroid dehydrogenase of proximal and distal nephron
Alfaidy, N., Blot‐Chabaud, M., Robic, D., Kenouch, S., Bourbouze, R., Bonvalet, J. P., & Farman, N. (1995) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(94)00173-u · Cited by 29
Testosterone: an overview of biosynthesis, transport, metabolism and action
Rommerts, F. F. G. (1990) · Testosterone · doi:10.1007/978-3-662-00814-0_1 · Cited by 28
Haque, M. R. U., Wilson, R. A., Sharma, K., Mills, N. J., & Teruyama, R. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12325 · Cited by 28
José, P. G. S., Arenas, C., Moral, I. C., Álvaro, P. C., & Alenza, M. D. P. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15841 · Cited by 28
“The MR has the same affinity to aldosterone and cortisol, but not to cortisone.(64-66) The enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD) converts cortisol in to cortisone, and it is abundantly expressed in the classical mineralocorticoid target tissues (eg, renal cortex, vascular endothelium and smooth muscle cell…”
BackgroundFan, P. T., Lu, Y., Yang, K., Zhang, D., Liu, X., Tian, T., Luo, F., Wang, L., Ma, W., Liu, Y., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02460-9 · Cited by 28
Menuet, D. L., Munier, M., Méduri, G., Viengchareun, S., & Lombès, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq087 · Cited by 28
Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess
Beck, K. R., & Odermatt, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111168 · Cited by 28
Madsen, K., Stubbe, J., Yang, T., Skøtt, O., Bachmann, S., & Jensen, B. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2003 · Cited by 28
Bienvenu, L. A., Reichelt, M. E., Morgan, J., Fletcher, E. K., Bell, J. R., Rickard, A. J., Delbridge, L. M. D., & Young, M. J. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05981 · Cited by 28
“MR ligand selectivity is regulated in a tissue-specific manner by the activity of 11β-hydroxysteroid dehydrogenase type 2,which converts glucocorticoids to inactive metabolites, resulting in MR being responsive to only mineralocorticoids.(25,26) Cardiomyocyte MR do not discriminate between glucocorticoid and mineraloc…”
BackgroundPiwien‐Pilipuk, G., & Galigniana, M. D. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00142-7 · Cited by 28
Li, C., Wang, W., Nørregaard, R., Knepper, M. A., Nielsen, S. S., & Frøkiær, J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00372.2006 · Cited by 28
Tissue specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase gene expression
Whorwood, C. B., Sheppard, M. C., & Stewart, P. M. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90180-5 · Cited by 28
Role of Glucocorticoid in the Development of Glycyrrhizin-Induced Hypertension
Kageyama, Y., Suzuki, H., & Saruta, T. (1994) · Clinical and Experimental Hypertension · doi:10.3109/10641969409078024 · Cited by 28
Flavonoids as hormones. A perspective from an analysis of molecular fossils.
Baker, M. E. (1998) · PubMed · Cited by 28
Takahashi, K., Fukushima, K., Sasano, H., Sasaki, I., Matsuno, S., Krozowski, Z. S., & Nagura, H. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026699324927 · Cited by 28
Baker, M. E. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5335-9_18 · Cited by 28
Pearce, D. (1994) · Steroids · doi:10.1016/0039-128x(94)90094-9 · Cited by 28
Seckl, J. R., Kelly, P. A. T., & Sharkey, J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90379-j · Cited by 28
Rat probasin: structure and function of an outlier lipocalin
Kasper, S., & Matusik, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00170-9 · Cited by 28
Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo
Escher, G., Meyer, K. V., Vishwanath, B. S., Frey, B. M., & Frey, F. J. (1995) · Endocrinology · doi:10.1210/endo.136.4.7895688 · Cited by 28
Ghosh, D., Erman, M., Pangborn, W. A., Duax, W. L., & Baker, M. E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90093-x · Cited by 28
Effects of Ziram on Rat and Human 11β-Hydroxysteroid Dehydrogenase Isoforms
Li, X., Mao, B., Dong, Y., Li, Y., Zhan, M., Bai, Y., Lian, Q., Ge, R., & Ye, L. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00527 · Cited by 27
Mongia, A. K., Vecker, R., George, M. M., Pandey, A., Tawadrous, H. K., Schoeneman, M. J., Muneyyirci‐Delale, O., Nacharaju, V. L., Ten, S., & Bhangoo, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1411 · Cited by 27
Transgenic mouse models to study human mineralocorticoid receptor function in vivo
Menuet, D. L., Zennaro, M., Viengchareun, S., & Lombès, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00966.x · Cited by 27
Chen, Z., Tsigelny, I. F., Lee, W. R., Baker, M. E., & Chang, S. H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01234-2 · Cited by 27
Methylation Increases the Open Probability of the Epithelial Sodium Channel in A6 Epithelia
Becchetti, A., Kemendy, A. E., Stockand, J. D., Sariban-Sohraby, S., & Eaton, D. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000954200 · Cited by 27
Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease
Zaehner, T., Plueschke, V., Frey, B. M., Frey, F. J., & Ferrari, P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00303.x · Cited by 27
“Its main function is the protection of the mineralocorticoid receptor (MR) from promiscuous access of endogenous glucocorticoids (GCs”
BackgroundPostnatal development of corticosteroid receptor immunoreactivity in the rat hippocampus
Lawson, A. N., Ahima, R. S., Krozowski, Z. S., & Harlan, R. E. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90191-k · Cited by 27
Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension
Walker, B. R., Aggarwal, I., Stewart, P. M., Padfield, P. L., & Edwards, C. R. W. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852515 · Cited by 27
Ferrari, P., Obeyesekere, V. R., Li, K., Andrews, R. K., & Krozowski, Z. S. (1996) · Steroids · doi:10.1016/0039-128x(96)00013-x · Cited by 27
Tempel, D. L., Kim, T., & LEIBOWITZ, S. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91035-q · Cited by 27
Nethathe, G. D., Lipman, J., Anderson, R., Fuller, P. J., & Feldman, C. H. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.10.034 · Cited by 27
Nicolaus Copernicus and the rapid vascular responses to aldosterone
Barton, M., & Meyer, M. R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.05.005 · Cited by 26
Kuhn, E., Bourgeois, C., Keo, V., Viengchareun, S., Muscat, A., Méduri, G., Menuet, D. L., Fève, B., & Lombès, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2013 · Cited by 26
Effect of licorice on PTH levels in healthy women
Mattarello, M. J., Benedini, S., Fiore, C., Camozzi, V., Sartorato, P., Luisetto, G., & Armanini, D. (2006) · Steroids · doi:10.1016/j.steroids.2006.01.005 · Cited by 26
Kim, S. W., Wang, W., Sassen, M. C., Choi, K. C., Han, J. S., Knepper, M. A., Jonassen, T., Frøkiær, J., & Nielsen, S. (2005) · Kidney International · doi:10.1038/sj.ki.5000018 · Cited by 26
Jellinck, P. H., Pavlides, C., Sakai, R. R., & McEwen, B. S. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00133-8 · Cited by 26
Wagner, M., Rudakova, E., & Volk, T. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0518-1 · Cited by 26
“In many epithelial tissues, MRs are protected against activation by glucocorticoids by the enzyme 11-βHSD2, which converts corticosterone to the receptor-inactive 11-dehydrocorticosterone [ 38 ], whereas MRs in cardiac myocytes are unprotected against corticosterone, since 11-βHSD2 is absent [39].”
BackgroundRicousse-Roussanne, S. L., Gouilleux, F., Fortin, D., Joulin, V., & Richard‐Foy, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5072 · Cited by 26
Clinical investigation of 11β-hydroxysteroid dehydrogenase
Walker, B. R., & Best, R. (1995) · Endocrine Research · doi:10.3109/07435809509030454 · Cited by 26
Juvenile Hypertension, the Role of Genetically Altered Steroid Metabolism
Ferrari, P., Bianchetti, M. G., & Frey, F. J. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049999 · Cited by 26
“In mineralocorticoid target tissues the microsomal enzyme 11β-hydroxysteroid dehydrogenase (11βHSD) [”
BackgroundHydroxysteroid dehydrogenases: ancient and modern regulators of adrenal and sex steroid action
Baker, M. E. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00399-9 · Cited by 26
Kidney 11β-HSD2 Is Inhibited by Glycyrrhetinic Acid-Like Factors in Human Urine
Lo, Y. H., Sheff, M. F., Latif, S. A., Ribeiro, C., Silver, H., Brem, A. S., & Morris, D. J. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.500 · Cited by 26
Shimada, S., Arai, T., Tamaoka, A., & Homma, M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014218 · Cited by 25
Bailey, M. A., Unwin, R. J., & Shirley, D. G. (2001) · Clinical Science · doi:10.1042/cs1010195 · Cited by 25
Aldosterone Reduces Crypt Colon Permeability during Low-Sodium Adaptation
Moretó, M., Cristià, E., Pérez‐Bosque, A., Afzal‐Ahmed, I., Amat, C., & Naftalin, R. J. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0772-5 · Cited by 25
Druce, L. A., Thorpe, C., & Wilton, A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.031 · Cited by 25
“The MR is protected from activation by cortisol by the enzyme 11b-HSD 2, which is colocalised with the MR receptor in renal cortical and medullary collecting ducts [15,16].”
BackgroundBocchi, B., Fagart, J., Cluzeaud, F., Fay, M., Rafestin-Oblin, M. E., & Farman, N. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00036-0 · Cited by 25
Saba, A., Raffaelli, A., Cupisti, A., Petri, A., Marcocci, C., & Salvadori, P. A. (2008) · Journal of Mass Spectrometry · doi:10.1002/jms.1530 · Cited by 25
Genetics of the mineralocorticoid system in primary hypertension
Ferrari, P. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0048-8 · Cited by 25
“However, in vivo, only aldosterone acts as a physiologic agonist of the MR. The MR is protected from promiscuous access of endogenous glucocorticoids by the microsomal 11βHSD, an enzyme that converts cortisol to the receptor inactive cortisone [ 11 ].”
BackgroundHuman Red Blood Cells Alterations in Primary Aldosteronism
Bordin, L., Donà, G., Sabbadin, C., Ragazzi, E., Andrisani, A., Ambrosini, G., Brunati, A. M., Clari, G., & Armanini, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3571 · Cited by 25
“Although Aldo is considered the primary physiological ligand in epithelial MRs, in other tissues Cort can bind the MR with a similarly high affinity and when circulating at higher concentrations (40) could strongly compete with Aldo for the binding.”
BackgroundYoshikawa, N., Makino, Y., Okamoto, K., Morimoto, C., Makino, I., & Tanaka, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107946200 · Cited by 25
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.